Kiora Pharmaceuticals Inc SEC filings KPRX
Kiora Pharmaceuticals Inc has 926 filings in SEC EDGAR's recent list, going back to Aug 9, 2006. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | May 28, 2026 | — |
| S-3 | Shelf registration | May 18, 2026 | — |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| S-3 | Shelf registration | Sep 15, 2025 | — |
| S-8 | Employee stock plan registration | Mar 25, 2025 | — |
| S-8 | Employee stock plan registration | May 10, 2024 | — |
| 424B3 | Prospectus | Mar 28, 2024 | — |
| S-3 | Shelf registration | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Oct 13, 2023 | — |
| 424B1 | Filing | Jun 2, 2023 | — |
| S-1/A | Amended registration statement | Jun 1, 2023 | — |
| FWP | Free writing prospectus | May 15, 2023 | — |
| S-1/A | Amended registration statement | May 12, 2023 | — |
| S-1 | Registration statement | May 5, 2023 | — |
| 424B3 | Prospectus | Feb 13, 2023 | — |
| S-1 | Registration statement | Feb 3, 2023 | — |
| 424B3 | Prospectus | Dec 28, 2022 | — |
| S-1 | Registration statement | Dec 22, 2022 | — |
| 424B3 | Prospectus | Nov 21, 2022 | — |
| S-8 | Employee stock plan registration | Oct 5, 2022 | — |
| 424B1 | Filing | Jul 25, 2022 | — |
| S-1/A | Amended registration statement | Jul 21, 2022 | — |
| S-1/A | Amended registration statement | Jul 19, 2022 | — |
| FWP | Free writing prospectus | Jul 14, 2022 | — |
| S-1/A | Amended registration statement | Jul 13, 2022 | — |
| S-1 | Registration statement | May 3, 2022 | — |
| S-8 | Employee stock plan registration | May 3, 2022 | — |
| 424B5 | Prospectus supplement | Aug 11, 2021 | — |
| 424B3 | Prospectus | Apr 30, 2021 | — |
| S-3 | Shelf registration | Apr 16, 2021 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 424B5 | Prospectus supplement | Dec 31, 2019 | — |
| 424B3 | Prospectus | Nov 18, 2019 | — |
| S-3/A | Filing | Nov 8, 2019 | — |
| S-3 | Shelf registration | Oct 18, 2019 | — |
| S-3/A | Filing | May 13, 2019 | — |
| S-8 | Employee stock plan registration | May 3, 2019 | — |
| S-3 | Shelf registration | May 3, 2019 | — |
| 424B4 | Prospectus | Apr 16, 2018 | — |
| FWP | Free writing prospectus | Apr 9, 2018 | — |
| S-1/A | Amended registration statement | Apr 9, 2018 | — |
| S-1 | Registration statement | Mar 23, 2018 | — |
| S-8 | Employee stock plan registration | Mar 2, 2018 | — |
| 424B4 | Prospectus | Jun 12, 2017 | — |
| S-1MEF | Filing | Jun 8, 2017 | — |
| S-1/A | Amended registration statement | Jun 5, 2017 | — |
| FWP | Free writing prospectus | May 5, 2017 | — |
| S-1/A | Amended registration statement | May 5, 2017 | — |
| S-1 | Registration statement | Apr 21, 2017 | — |
| S-8 | Employee stock plan registration | Feb 24, 2017 | — |
| 424B5 | Prospectus supplement | Feb 22, 2017 | — |
| S-3 | Shelf registration | Aug 31, 2016 | — |
| 424B5 | Prospectus supplement | Jun 28, 2016 | — |
| 424B5 | Prospectus supplement | Jun 27, 2016 | — |
| 424B5 | Prospectus supplement | May 25, 2016 | — |
| S-3/A | Amendment no. 2 | May 3, 2016 | — |
| S-3/A | Filing | Apr 15, 2016 | — |
| S-3 | Shelf registration | Apr 1, 2016 | — |
| S-8 | Employee stock plan registration | Feb 9, 2016 | — |
| 424B3 | Prospectus | Nov 12, 2015 | — |
| 424B3 | Prospectus | Aug 12, 2015 | — |
| 424B4 | Prospectus | Jul 31, 2015 | — |
| S-1/A | Amended registration statement | Jul 30, 2015 | — |
| S-1/A | Amended registration statement | Jul 30, 2015 | — |
| S-1/A | Amended registration statement | Jul 28, 2015 | — |
| FWP | Free writing prospectus | Jul 16, 2015 | — |
| S-1/A | Amended registration statement | Jul 15, 2015 | — |
| S-1 | Registration statement | Jun 5, 2015 | — |
| S-8 | Employee stock plan registration | Feb 20, 2015 | — |
| 424B4 | Prospectus | Feb 13, 2015 | — |
| S-1/A | Amended registration statement | Feb 4, 2015 | — |
| S-1/A | Amended registration statement | Jan 26, 2015 | — |
| FWP | Free writing prospectus | Jan 16, 2015 | — |
| S-1/A | Amended registration statement | Dec 24, 2014 | — |
| S-1/A | Amended registration statement | Dec 2, 2014 | — |
| S-1/A | Amended registration statement | Nov 20, 2014 | — |
| FWP | Free writing prospectus | Oct 24, 2014 | — |
| FWP | Free writing prospectus | Sep 29, 2014 | — |
| S-1/A | Amended registration statement | Sep 29, 2014 | — |
| FWP | Free writing prospectus | Sep 12, 2014 | — |
| S-1/A | Amended registration statement | Sep 12, 2014 | — |
| S-1/A | Amended registration statement | Aug 29, 2014 | — |
| S-1/A | Amended registration statement | Aug 8, 2014 | — |
| S-1 | Registration statement | Jul 30, 2014 | — |
Showing 84 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KPRX (Nasdaq), KPHMW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Encinitas, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1372514
- Former names
- EYEGATE PHARMACEUTICALS INC (until Nov 4, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.